Skip to main content
Equibles
MIRM logo

MIRM · Mirum Pharmaceuticals, Inc. · Metrics

Track MIRM — free

Use MIRM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MIRM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$84.68 +2.44 (+2.97%)
Russell 2000 member Rebalance outlook locked
Market Cap
$5.34B
Shares
64.93M
Volume · Oct 20 64.05K Avg daily vol (3M) 724.25K

MIRM metrics

67 of 116 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$82.24
Market cap
$5.34B

Price action

20 metrics
Price change (1W)
-4.4%
Price change (30D)
-10.6%
Price change (3M)
-29.5%
Price change (6M)
-14.1%
Price change (YTD)
+4.1%
Price change (1Y)
+11.8%
Trailing year
Price change (5Y)
+399.0%
52-week high
$128.57
52-week low
$64.10
Change from 52-week high
-36.0%
Change from 52-week low
+28.3%
Annualized volatility
47.5%
Annualized volatility (3M)
46.1%
Beta
1.1
RSI (14D)
41.1
Price vs SMA 50
-11.3%
Price vs SMA 200
-16.5%
Avg volume (3M)
724,246
Relative volume
0.6
Average dollar volume
$68.76M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
64.93M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.4×
reciprocal yield 11.9%
P / book
—
FCF yield
-4.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-16.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
7.3×
reciprocal yield 13.8%
EV / revenue historical average (5Y)
7.3×
reciprocal yield 13.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
-134.9%
Trailing 12 months
Net margin
-139.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$833.97M
Net income (TTM)
−$860.21M
Trailing 12 months
Diluted EPS (TTM)
$-14.54
FCF margin
-37.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.06

Growth

11 metrics
Revenue growth YoY
+37.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$618.07M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+27.4%
Year over year · more shares
Revenue CAGR (3Y)
+89.1%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-82.3%
Debt / equity
—
Current ratio
2.9
EBITDA (TTM)
−$808.02M
Free cash flow (TTM)
−$228.74M
Quick ratio
2.7
Interest coverage
-62.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$438.29M
Latest balance sheet
Cash & equivalents
$330.73M
Total assets
$1.04B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$227.27M
Capital expenditures (TTM)
$1.47M
R&D (TTM)
$287.50M
SG&A (TTM)
$313.84M
Stock compensation (TTM)
$103.93M
R&D / revenue
46.5%
Stock compensation / revenue
16.8%

Ownership (13F)

3 metrics
13F filers
330
13F filer change QoQ
+16
Institutional ownership
110.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.4%

Short interest

3 metrics
Short interest
10.8%
Latest settlement · 7.7 days to cover
Days to cover
7.7d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$10.78M
Insider-sentiment score
19 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1759425 CUSIP 604749101 13F (30d) 26 filings 25 filers Visit website Investor relations